Literature DB >> 27045122

Ebola Virus Persistence in Semen of Male Survivors.

Timothy M Uyeki1, Bobbie Rae Erickson1, Shelley Brown1, Anita K McElroy1,2, Deborah Cannon1, Aridth Gibbons1, Tara Sealy1, Markus H Kainulainen1, Amy J Schuh1, Colleen S Kraft2, Aneesh K Mehta2, G Marshall Lyon2, Jay B Varkey2, Bruce S Ribner2, Richard T Ellison3, Ellie Carmody4, Gerard J Nau5, Christina Spiropoulou1, Stuart T Nichol1, Ute Ströher1.   

Abstract

We investigated the duration of Ebola virus (EBOV) RNA and infectious EBOV in semen specimens of 5 Ebola virus disease (EVD) survivors. EBOV RNA and infectious EBOV was detected by real-time RT-PCR and virus culture out to 290 days and 70 days, respectively, after EVD onset. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Ebola virus; semen; sexual transmission

Mesh：

Year:  2016        PMID： 27045122     DOI： 10.1093/cid/ciw202

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  52 in total

1.  Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.

Authors:  John C Kash; Kathie-Anne Walters; Jason Kindrachuk; David Baxter; Kelsey Scherler; Krisztina B Janosko; Rick D Adams; Andrew S Herbert; Rebekah M James; Spencer W Stonier; Matthew J Memoli; John M Dye; Richard T Davey; Daniel S Chertow; Jeffery K Taubenberger
Journal:  Sci Transl Med       Date:  2017-04-12       Impact factor: 17.956

2.  Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys.

Authors:  Xiankun Zeng; Candace D Blancett; Keith A Koistinen; Christopher W Schellhase; Jeremy J Bearss; Sheli R Radoshitzky; Shelley P Honnold; Taylor B Chance; Travis K Warren; Jeffrey W Froude; Kathleen A Cashman; John M Dye; Sina Bavari; Gustavo Palacios; Jens H Kuhn; Mei G Sun
Journal:  Nat Microbiol       Date:  2017-07-17       Impact factor: 17.745

3.  Enhancement of Ebola virus infection by seminal amyloid fibrils.

Authors:  Stephen M Bart; Courtney Cohen; John M Dye; James Shorter; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

Review 4.  Exosomes in Viral Disease.

Authors:  Monique R Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

5.  A Longitudinal Study of Ebola Sequelae in Liberia.

Authors:  Michael C Sneller; Cavan Reilly; Moses Badio; Rachel J Bishop; Allen O Eghrari; Soka J Moses; Kumblytee L Johnson; Dehkontee Gayedyu-Dennis; Lisa E Hensley; Elizabeth S Higgs; Avindra Nath; Kaylie Tuznik; Justin Varughese; Kenneth S Jensen; Bonnie Dighero-Kemp; James D Neaton; H Clifford Lane; Mosoka P Fallah
Journal:  N Engl J Med       Date:  2019-03-07       Impact factor: 91.245

6.  Novel Stable Ebola Virus Minigenome Replicon Reveals Remarkable Stability of the Viral Genome.

Authors:  Wanyin Tao; Tianyu Gan; Mingzhe Guo; Yongfen Xu; Jin Zhong
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

7.  Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae.

Authors:  Stephanie M LaVergne; Saori Sakabe; Lansana Kanneh; Mambu Momoh; Foday Al-Hassan; Mohamed Yilah; Augustine Goba; John Demby Sandi; Michael Gbakie; Beatrice Cubitt; Matthew Boisen; Jessica M Mayeux; Ashley Smira; Kayla Shore; Iris Bica; K Michael Pollard; Juan Carlos de la Torre; Luis M Branco; Robert F Garry; Donald S Grant; John S Schieffelin; Michael B A Oldstone; Brian M Sullivan
Journal:  J Infect Dis       Date:  2020-10-01       Impact factor: 5.226

8.  A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.

Authors:  Anita K McElroy; Rama S Akondy; Jessica R Harmon; Ali H Ellebedy; Deborah Cannon; John D Klena; John Sidney; Alessandro Sette; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Stuart T Nichol; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

9.  Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.

Authors:  Priya Luthra; Jacinth Naidoo; Colette A Pietzsch; Sampriti De; Sudip Khadka; Manu Anantpadma; Caroline G Williams; Megan R Edwards; Robert A Davey; Alexander Bukreyev; Joseph M Ready; Christopher F Basler
Journal:  Antiviral Res       Date:  2018-08-23       Impact factor: 5.970

10.  Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA.

Authors:  Emily P Thi; Amy C H Lee; Joan B Geisbert; Raul Ursic-Bedoya; Krystle N Agans; Marjorie Robbins; Daniel J Deer; Karla A Fenton; Andrew S Kondratowicz; Ian MacLachlan; Thomas W Geisbert; Chad E Mire
Journal:  Nat Microbiol       Date:  2016-08-22       Impact factor: 17.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.